[{"address1": "16 Abba Hillel Road", "city": "Ramat Gan", "zip": "5250608", "country": "Israel", "phone": "972 3 693 8448", "fax": "972 3 693 8447", "website": "https://galmedpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Allen  Baharaff", "age": 59, "title": "Co-Founder, President, CEO & Chairman", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1467116, "exercisedValue": 0, "unexercisedValue": 4940}, {"maxAge": 1, "name": "Mr. Doron  Cohen", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 252093, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Guy  Nehemya", "age": 39, "title": "COO & Data Protection Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 294347, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yohai  Stenzler CPA", "age": 41, "title": "Chief Accounting Officer", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 298107, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Liat  Hayardeny MBA, Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tali  Gorfine", "age": 54, "title": "Medical Consultant", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 202763, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.56, "open": 1.6, "dayLow": 1.5404, "dayHigh": 1.629, "regularMarketPreviousClose": 1.56, "regularMarketOpen": 1.6, "regularMarketDayLow": 1.5404, "regularMarketDayHigh": 1.629, "payoutRatio": 0.0, "beta": 0.501, "forwardPE": -1.524272, "volume": 63187, "regularMarketVolume": 63187, "averageVolume": 227784, "averageVolume10days": 58830, "averageDailyVolume10Day": 58830, "bid": 1.51, "ask": 1.63, "bidSize": 1, "askSize": 1, "marketCap": 8602393, "fiftyTwoWeekLow": 1.15, "fiftyTwoWeekHigh": 4.81, "allTimeHigh": 4870.8, "allTimeLow": 1.15, "fiftyDayAverage": 1.4805, "twoHundredDayAverage": 1.900245, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -12202212, "profitMargins": 0.0, "floatShares": 5229815, "sharesOutstanding": 5479231, "sharesShort": 98393, "sharesShortPriorMonth": 62814, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.018, "heldPercentInsiders": 0.01193, "heldPercentInstitutions": 0.01418, "shortRatio": 0.45, "shortPercentOfFloat": 0.0182, "impliedSharesOutstanding": 5479231, "bookValue": 3.87, "priceToBook": 0.40568477, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -8722000, "trailingEps": -5.61, "forwardEps": -1.03, "lastSplitFactor": "1:12", "lastSplitDate": 1724976000, "enterpriseToEbitda": 1.747, "52WeekChange": -0.61800486, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 1.57, "recommendationKey": "none", "totalCash": 20528000, "totalCashPerShare": 3.871, "ebitda": -6986500, "totalDebt": 0, "quickRatio": 8.658, "currentRatio": 8.709, "returnOnAssets": -0.24211, "returnOnEquity": -0.53989, "freeCashflow": -3760750, "operatingCashflow": -5468000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GLMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Galmed Pharmaceuticals Ltd.", "longName": "Galmed Pharmaceuticals Ltd.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1759535034, "regularMarketTime": 1759521600, "exchange": "NCM", "messageBoardId": "finmb_114779940", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "earningsTimestampStart": 1756238400, "earningsTimestampEnd": 1756756800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.61, "epsForward": -1.03, "fiftyDayAverageChange": 0.08950007, "fiftyDayAverageChangePercent": 0.0604526, "twoHundredDayAverageChange": -0.3302449, "twoHundredDayAverageChangePercent": -0.1737907, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394717400000, "postMarketChangePercent": 1.91083, "postMarketPrice": 1.6, "postMarketChange": 0.03, "regularMarketChange": 0.0100001, "regularMarketDayRange": "1.5404 - 1.629", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 227784, "fiftyTwoWeekLowChange": 0.42000008, "fiftyTwoWeekLowChangePercent": 0.36521748, "fiftyTwoWeekRange": "1.15 - 4.81", "fiftyTwoWeekHighChange": -3.2399998, "fiftyTwoWeekHighChangePercent": -0.6735966, "fiftyTwoWeekChangePercent": -61.800488, "regularMarketChangePercent": 0.641033, "regularMarketPrice": 1.57, "displayName": "Galmed Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]